MD | DC | VA
Our Goal: To become a Top 3 BioHealth Hub by 2023.
Driving Innovation and Entrepreneurship
- World–renowned research institutions and universities
- Influential policymakers and advocacy groups pioneering new health strategies
- World–leading infectious disease research and vaccine development
- Fastest growing region for healthcare companies in the U.S.
- Rated #1 in the nation for science and engineering talent
- Mission control for the National Cancer Moonshot Initiative
Founding Partners
Regenxbio will construct a GMP facility in Maryland to produce adeno-associated viral vectors for its gene therapy programs using its NAV technology-based platform. The good manufacturing practice (GMP) plant will…
HILDEN, Germany & GERMANTOWN, Md.–(BUSINESS WIRE)–May 21, 2019– QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that QuantiFERON ® -TB Access, a new solution under development for diagnosis…
PRINCETON, N.J., May 21, 2019 /PRNewswire/ — Navitas Life Sciences, a TAKE Solutions Enterprise today announced the acquisition of US based niche full service CRO and health research company, KAI Research Inc. KAI Research…
ROCKVILLE, Md.–(BUSINESS WIRE)– Helps Fund Wet Lab Space for Small Biotech Companies The Montgomery County Economic Development Corporation (MCEDC) launches a year-long pilot program designed to help small biotech companies…
The net proceeds from the IPO, along with NextCure’s cash on hand, will largely be used to drive its lead product, NC318, through clinical trials and testing. Read more via…
The 2019 Tech Showcase Focuses on Partnerships, Entrepreneurship and Business Resources for Commercializing Technologies May 7, 2019 What do the technologies that led to the success of Kite Pharma, the…